Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled AsthmaPRNewsWire • 02/26/21
Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque PsoriasisPRNewsWire • 02/22/21
FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung CancerPRNewsWire • 02/16/21
The $12 Billion Market That Has Biotech Stocks Hijacking The Immune SystemInvestors Business Daily • 02/12/21
Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/03/21
Amgen Stock Dives On Light 2021 Outlook Despite Fourth-Quarter BeatInvestors Business Daily • 02/02/21
Week 5 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 02/01/21